Noah
Noah scored 70/100 on Panya's 11-signal vendor rubric. Each signal is scored 0 to 100, the methodology is public, and our affiliate posture is flat-fee · never pay-to-rank. Below is the full per-signal breakdown.
- COA on every lot75
- Cold-chain verified4-hour SG-domestic75
- Rx legality (HSA)HCSA licensed; MOH 87/2024 copy thin90
- Compound identity75
- Dose accuracySMC-licensed GP, not endo75
- Endotoxin testing65
- Refund postureno lock-ins65
- Channel clarity$20.10 first consult published95
- Support quality100k+ patients OF group80
- Price transparency$/day not $/month70
- Longitudinal retentionfree follow-ups, no app/biomarkers55
HSA-registered; longevity clinics + hybrid telehealth all stocking. No reported gaps.
More reliable than Wegovy at most SG providers.
Demand outstripped supply post-2024; expect 1-3 week stock gaps at retail apoteks. Hybrid telehealth platforms substitute Ozempic when Wegovy runs dry.
The 11-signal rubric is public.
Identity, dose accuracy, COA, cold-chain, Rx legality, compound identity, endotoxin testing, refund posture, channel clarity, support quality, price transparency, longitudinal retention. Each scored 0 to 100. Vendors that fail our floor are silently filtered out · they don't appear in our match flow at all.
If Noah wants to dispute or update this score, contact partner@panya.health. Score updates are recorded on this page with a public changelog.
Want a match for your situation?
Take the 2-minute quiz. We'll match you against this and the other vendors in your region · based on your dose, urgency, and budget.
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.